INDONESIAN VERSION OF THE PAINDETECT QUESTIONNAIRE IN THE ASSESSMENT OF NEUROPATHIC PAIN: A VALIDITY AND RELIABILITY STUDY

Authors

  • Karolina Margareta Department of Neurology Faculty of Medicine, University of Indonesia / Cipto Mangunkusumo Hospital
  • Manfaluthy Hakim Department of Neurology Faculty of Medicine, University of Indonesia / Cipto Mangunkusumo Hospital
  • Mohammad Kurniawan Department of Neurology Faculty of Medicine, University of Indonesia / Cipto Mangunkusumo Hospital
  • Tiara Anindhita Department of Neurology Faculty of Medicine, University of Indonesia / Cipto Mangunkusumo Hospital
  • Herqutanto Department of Public Health Faculty of Medicine, University of Indonesia / Cipto Mangunkusumo Hospital

Keywords:

neuropathic pain; chronic pain; validity dan realibility; painDETECT quesstionnaire

Abstract

Objective: To develop an Indonesian version of PainDETECT Questionnaire (PDQ-Ina) and assess its
validity and reliability. Methode: The validity and reliability study was conducted at the Neurology Clinic
Cipto Mangunkusumo General Hospital, Jakarta from March 2014 until May 2014 using cross sectional
design. Sample of the research was done by non random consecutive sampling method. and were taken
from each participant who met the inclusion criteria, measuring reliability of painDETECT Questionnaires
(PDQ) using statistical analysis and retest test method within 24-48 hours interval. Result:There were
150 subjects with chronic pain. Divided in to 3 types of group based on Indonesian version PDQ scoring,
75 patients having nociceptive pain, 42 were mixed pain and 33 patients having neuropathic pain. Within
validation criteria analysis there were high correlation between PDQ-Ina with LANSS instrument as gold
standard (r= 0,082,p<0,001), AUC 85,5%, sensitivity 78,3% and specificity 78,7% with the optimal cut off
point ≥17. The reliability of internal consistency Cronbach’s Alpha value were 0,710 and the test retest
realibility were 0,96. Conclusion :The Indonesian version of the PDQ is a valid and reliable scale and
have a good sensitivity and specificity to be used to determine neuropathic component of chronic pain.

Published

2021-06-07